All cases (eventsb=91) | Luminal A (eventsb=31) | Luminal B (eventsb=21) | HER2-enriched (eventsb=15) | TNBC (eventsb=24) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
N | HR (95% CI) | n | HR (95% CI) | n | HR (95% CI) | n | HR (95% CI) | n | HR (95% CI) | |
Triglycerides | ||||||||||
Continuous, mmol/l | 446 | 1.01 (0.88–1.22) | 224 | 0.88 (0.40–1.92) | 94 | 0.76 (0.23–2.46) | 41 | 1.01 (0.71–1.47) | 87 | 1.12 (0.73–1.64) |
Tertiles | ||||||||||
≤ 0.82 mmol/l | 148 | 1.00 | 76 | 1.00 | 33 | 1.00 | 13 | 1.00 | 26 | 1.00 |
0.83–1.22 mmol/l | 152 | 0.81 (0.47–1.40) | 77 | 1.26 (0.51–3.11) | 31 | 0.24 (0.06–0.89) | 13 | 0.27 (0.04–1.91) | 31 | 1.37 (0.37–4.98) |
≥ 1.23 mmol/l | 146 | 1.23 (0.71–2.13) | 71 | 1.02 (0.38–2.68) | 30 | 0.42 (0.12–1.52) | 15 | 0.26 (0.03–2.54) | 30 | 5.63 (1.64–19.3) |
p-trend | 0.308 | 0.854 | 0.081 | 0.422 | 0.004 | |||||
HDL-cholesterol/total-cholesterol ratio | ||||||||||
Continuous | 446 | 1.18 (0.09–15.7) | 224 | 16.4 (0.18–1.4e4) | 94 | 15.0 (0.04–6.2e4) | 41 | 116 (0.00–4.3e6) | 87 | 0.03 (0.00–6.86) |
Tertiles | ||||||||||
≤ 0.27 | 147 | 1.00 | 74 | 1.00 | 29 | 1.00 | 21 | 1.00 | 23 | 1.00 |
0.28–0.34 | 149 | 1.16 (0.70–1.93) | 66 | 1.52 (0.58–4.02) | 36 | 5.13 (0.98–20.7) | 13 | 1.27 (0.31–5.21) | 34 | 0.58 (0.22–1.56) |
≥ 0.35 | 150 | 1.02 (0.58–1.78) | 84 | 1.87 (0.69–5.07) | 29 | 2.06 (0.55–7.75) | 7 | 2.99 (0.43–20.8) | 30 | 0.32 (0.10–1.06) |
p-trend | 0.808 | 0.219 | 0.344 | 0.310 | 0.060 |